Stelis concludes US$ 195m Series B and Series C fund raise
Significant interest from marquee long term investors
19-मार्च-2021
डाउनलोड पीडीएफ़
Strides Pharma
Stelis concludes US$ 195m Series B and Series C fund raise
Significant interest from marquee long term investors